Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Breast Cancer
Interventions
DRUG

Tc99m sestamibi

Given by IV

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER